menu
    • menu

    Company profile for Cardurion Pharmaceutical

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cardurion is a Boston-based cardiovascular biotechnology company developing new therapeutics for the treatment of heart failure and cardiovascular diseases. In July, 2017, Takeda Pharmaceutical Company Limited and Cardurion Pharmaceuticals announced the creation of a new preclinical partnership to develop novel, next-generation therapeutics for the treatment of heart failure and cardiovascular diseases. The partnership with Ca...
    Cardurion is a Boston-based cardiovascular biotechnology company developing new therapeutics for the treatment of heart failure and cardiovascular diseases. In July, 2017, Takeda Pharmaceutical Company Limited and Cardurion Pharmaceuticals announced the creation of a new preclinical partnership to develop novel, next-generation therapeutics for the treatment of heart failure and cardiovascular diseases. The partnership with Cardurion follows Takeda’s strategy to leverage external innovation by placing selected assets and outstanding scientists in an entrepreneurial setting and enables the Discovery programs of Cardurion.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cardurion PharmaceuticalUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1 Lincoln Street, 30th Floor Boston, MA 02111
    Telephone
    Telephone
    617-863-8088
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cardurion.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cardurion Pharma finishes Phase 2 CYCLE trials of CRD-750
    Cardurion Pharma finishes Phase 2 CYCLE trials of CRD-750

    06 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/06/3128280/0/en/Cardurion-Pharmaceuticals-Completes-Enrollment-in-Phase-2-CYCLE-Trials-Evaluating-CRD-750-a-Novel-PDE9-inhibitor-in-Heart-Failure.html

    GLOBENEWSWIRE
    06 Aug 2025
    Share Share
    Cardurion Pharmaceuticals Names Karen Lewis Chief People Officer
    Cardurion Pharmaceuticals Names Karen Lewis Chief People Officer

    20 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250320903077/en/Cardurion-Pharmaceuticals-Appoints-Karen-Lewis-as-Chief-People-Officer

    BUSINESSWIRE
    20 Mar 2025
    Share Share
    Cardurion Pharma Appoints Charlotte as Chief Business Officer
    Cardurion Pharma Appoints Charlotte as Chief Business Officer

    08 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250108574324/en

    BUSINESSWIRE
    08 Jan 2025
    Share Share
    Cardurion Pharmaceuticals Selected As Endpoints 11 Company
    Cardurion Pharmaceuticals Selected As Endpoints 11 Company

    27 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240927193940/en

    BUSINESSWIRE
    27 Sep 2024
    Share Share
    Cardurion Pharmaceuticals Appoints Ron Renaud to Board of Directors
    Cardurion Pharmaceuticals Appoints Ron Renaud to Board of Directors

    26 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240926274215/en

    BUSINESSWIRE
    26 Sep 2024
    Share Share
    Cardio-focused Cardurion raises hearty $260M series B
    Cardio-focused Cardurion raises hearty $260M series B

    16 Jul 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/cardio-focused-cardurion-closes-hearty-260-million-series-b

    FIERCE BIOTECH
    16 Jul 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search